Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affo rdable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
...Read MoreAmneal Pharmaceuticals
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals Inc
Amneal Biosciences LLC
Vertical Pharmaceuticals LLC
$2.5 B
7,850
2002
Amneal Pharmaceuticals raised a total of $250 M in funding over 1 rounds, and is a public traded company.
NASDAQ: AMRX
Here's a list of some of the top trending technologies and APIs used by Amneal Pharmaceuticals.
(17 Technologies)
(16 Technologies)
(16 Technologies)
(14 Technologies)
(14 Technologies)
Company | Employees | Revenue | Top technologies |
---|---|---|---|
Endo | 2,995 | $2 B | |
Sun Pharma | 38 K | $5.7 B | |
Lannett | 564 | $453.8 M | |
Premier Research | 2,000 | $617.6 M | |
Biogen | 7,570 | $9.7 B |